T
Tivic Health Systems, Inc. (TIVC)
NCM – Real vaqt narxi. Valyuta: USD
1.40
+1.40 (0.00%)
Yopilishda: Apr 27, 2026, 4:00 PM EDT
Aksiya tahlili uchun eng kuchli vositalarga ega bo'ling
Find any stock by ticker or company name
NCM – Real vaqt narxi. Valyuta: USD
1.40
+1.40 (0.00%)
Yopilishda: Apr 27, 2026, 4:00 PM EDT
Tivic Health Systems, Inc. kechki bosqich immunoterapiya kompaniyasi sifatida faoliyat yuritadi. Uning asosiy dorisi nomzodi Entolimod, bu o'tkir radiatsiya sindromini davolash uchun kechki bosqichda ishlab chiqilayotgan TLR5 agonisidir. Kompaniya portfelida neutropeniya va limfotsitlar charchashini davolash uchun Entolimod; va surunkali qo'llash uchun Entolimodning immunologik optimallashtirilgan varianti bo'lgan Entolasta ham mavjud. Bundan tashqari, u CDMO xizmatlarini taklif etadi. Kompaniya 2016 yilda tashkil etilgan va Fremont, Kaliforniyada joylashgan.
| Ism | Lavozim |
|---|---|
| Mr. Michael Kevin Handley | CEO & Director |
| Ms. Lisa G. Wolf | CFO and Principal Financial & Principal Accounting Officer |
| Sana | Turi | Hujjat |
|---|---|---|
| 2026-04-23 | 8-K | tivic_8k.htm |
| 2026-04-20 | PRE 14A | tivic_pre14a.htm |
| 2026-04-13 | S-1 | tivic_s1.htm |
| 2026-04-06 | DRS | filename1.htm |
| 2026-03-30 | 10-K | tivc20251231_10k.htm |
| 2026-03-25 | 8-K | tivc20251119_8k.htm |
| 2026-03-20 | 8-K | tivic_8k.htm |
| 2026-03-13 | 8-K | tivic_8k.htm |
| 2026-03-11 | 8-K | tivic_8k.htm |
| 2026-03-04 | 8-K | tivic_8k.htm |